Prostate specific antigen and local recurrence after radical prostatectomy.

Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound.

Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason score.

Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy.

Postoperative prostate-specific antigen monitoring interval for radical prostatectomy patients with low recurrence risk.

Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy.

Recurrence of prostate cancer with cutaneous metastasis after radical prostatectomy.

Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.

Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy.

Usefulness of ultra-sensitive prostate-specific antigen following radical prostatectomy.

Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review.

Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.

Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?

Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy.

Low detectable prostate specific antigen after radical prostatectomy--treat or watch?

Salvage HIFU for biopsy confirmed local prostate cancer recurrence after radical prostatectomy and radiation therapy: Case report and literature review.

Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation)

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer.

Serum prostate-specific antigen after post-prostatectomy radiotherapy.

Salvage low-dose-rate brachytherapy for prostate cancer local recurrence after radical prostatectomy: our first three patients.

Defining prostate cancer risk after radical prostatectomy.

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer.

Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy.

Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy.

Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy-What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?

Suggest Documents

Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound.

Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason score.

Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy.

Postoperative prostate-specific antigen monitoring interval for radical prostatectomy patients with low recurrence risk.

Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy.

Recurrence of prostate cancer with cutaneous metastasis after radical prostatectomy.

Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.

Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy.

Usefulness of ultra-sensitive prostate-specific antigen following radical prostatectomy.

Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review.

Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.

Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?

Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy.

Low detectable prostate specific antigen after radical prostatectomy--treat or watch?

Salvage HIFU for biopsy confirmed local prostate cancer recurrence after radical prostatectomy and radiation therapy: Case report and literature review.

Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation)

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer.

Serum prostate-specific antigen after post-prostatectomy radiotherapy.

Salvage low-dose-rate brachytherapy for prostate cancer local recurrence after radical prostatectomy: our first three patients.

Defining prostate cancer risk after radical prostatectomy.

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer.

Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy.

Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy.

Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy-What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?

Prostate specific antigen and local recurrence after radical prostatectomy.

Recommend Documents

Follow Us